Publications

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

28 July 2011

The Lancet

Injecting drug use is an important risk factor for transmission of viral hepatitis, but detailed, transparent estimates of the scale of the issue do not exist. We estimated national, regional, and global prevalence and population size for hepatitis C virus (HCV) and hepatitis B virus (HBV) in injecting drug users (IDUs).

More IDUs have anti-HCV than HIV infection, and viral hepatitis poses a key challenge to public health. Variation in the coverage and quality of existing research creates uncertainty around estimates. Improved and more complete data and reporting are needed to estimate the scale of the issue, which will inform efforts to prevent and treat HCV and HBV in IDUs.

Related Profiles

  • Paul Nelson
  • Louisa Degenhardt
  • Holly Hagan
  • Don C. Des Jarlais
  • Danielle Horyniak
  • Bradley Mathers
  • Benjamin Cowie